STAMPEDE / LATITUDE coverage overview 2017 ASCO Annual Meeting Artwork: Cliff Enright, Star Cradle th Artwork from The Creative Center Last updated 9 June 2017 at University Settlement EU Coverage Snapshot 2 UK 3 4 5 6 7 8 9 France: More 80 articles in 3 days… France: Broad coverage across different media . Online general media: leparisien.fr, lepoint.fr, oues- France.fr, sciencesetavenir, Femme Actuelle, les Echos, Boursorama . National Press Agency: AFP (all regional daily papers will probably replicate the story) . Online TV and radios: France Inter, France 24, TV5 Monde, Europe 1, France Télévision . Online regional media: Paris Normandie, Ouest France, la Dépêche, le Télégramme, la Provence, le Courrier de l’Ouest, Centre presse . Online medical media: Pourquoi Docteur, K Onco, Cancer.fr, la lettre du cancérologue, Doctissimo, docteurjd . Print National Media: Le Monde, le Parisien 11 Nordics: Spread from Trade Titles to Lay Press 12 Sweden 13 Sweden 14 Sweden 15 http://www.sydostran.se/tt-inrikes/battre-prognos-for-manlig-cancer/ 16 Denmark 17 Denmark 18 - Denmark continued 19 Norway 20 Norway 21 Finland 22 Finland 23 Finland 24 Finland 25 Germany 26 Germany 27 Germany 28 Netherlands/ Belgium 29 Italy 30 Italy 31 Italy 32 Coverage summary DATE PUBLICATION LINK 02.06.17 The Pharma Letter https://www.thepharmaletter.com/article/zytiga-results-transformational-says-janssen-s-oncology-vp http://ecancer.org/news/11710-asco-2017--latitude-trial-of-abiraterone-for-metastatic-prostate-cancer- 03.06.17 Ecancer doubles-median-pfs.php http://www.bioportfolio.com/news/article/3168259/ASCO-2017-LATITUDE-trial-of-abiraterone-for- 03.06.17 BioPortfolio metastatic-prostate-cancer-delays-growth.html http://www.cancernetwork.com/asco-prostate-cancer/abiraterone-adt-combo-increased-prostate-cancer- 03.06.17 Cancer Network survival http://www.fiercepharma.com/pharma/j-j-s-zytiga-slashes-death-risk-by-38-earlier-stage-prostate-cancer- 03.06.17 Fierce Pharma patients http://clinicaltrials.pharmaceutical-business-review.com/news/jjs-prostate-cancer-drug-zytiga-shows- 05.06.17 Pharmaceutical Business Review significant-effect-in-phase-3-trial-050617-5833030 05.06.17 Scrip TBC 05.06.17 Pharmacy Choice http://www.pharmacychoice.com/news/article.cfm?Article_ID=1769027 06.06.17 serengo.net N/A 06.06.17 LE TRIBUNE N/A 33 Coverage summary DATE PUBLICATION LINK 03.06.17 Boursorama.com N/A N/A 03.06.17 bienpublic.com 03.06.17 portail.free.fr N/A 04.06.17 leparisien.fr N/A 04.06.17 CENTRE PRESSE AVEYRON N/A 04.06.17 femmeactuelle.fr N/A 04.06.17 pourquoidocteur.fr N/A 04.06.17 24matins.fr N/A http://portail.free.fr/lifestyle/forme/7045638_20170603_avancee-importante-contre-le-cancer-de-la- 04.06.17 portail.free.fr prostate.html 04.06.17 businesswire.fr N/A 04.06.17 itespresso.fr N/A 04.06.17 LE TELEGRAMME N/A 04.06.17 OUEST FRANCE N/A 04.06.17 AUJOURD'HUI EN FRANCE N/A 34 Coverage summary DATE PUBLICATION LINK http://lecancer.fr/congres/congres-americain-cancerologie-2017-pharma/congres-americain-cancerologie-2017- 05.06.17 serengo.net pharma-4juin/lacetate-dabiraterone-permet-aux-porteurs-de-cancer-de-prostate-metastatiques-delargir- drastiquement-leurs-perspectives/ 05.06.17 news.radins.com https://news.radins.com/actualites/cancer-la-prostate-un-nouveau-traitement-prometteur,35561.html 05.06.17 femmeactuelle.fr N/A 05.06.17 francetvinfo.fr N/A 05.06.17 feminactu.com N/A http://www.augsburger-allgemeine.de/wissenschaft/Hoehere-Lebenserwartung-bei-Prostatakrebs-neue-Therapie- 06.06.16 augsburger-allgemeine.de id41647726.html 06.06.16 http://www.t-online.de/gesundheit/krankheiten-symptome/krebs/id_81371522/franzoesische-forscher-bremsen- t-online.de prostatakrebs.html 06.06.16 Het Nieuwsbla N/A 06.06.16 The Age N/A 06.06.16 De Tijd N/A 06.06.16 Destination Sante N/A 06.06.16 Le Republican Lorrain N/A 06.06.16 eei-biotechfinances.com N/A 06.06.16 destinationsante.com N/A 06.06.16 medisite.fr N/A 06.06.16 letempsdesbanlieues.com N/A 35 Coverage summary DATE PUBLICATION LINK http://www.cancernetwork.com/asco-prostate-cancer/stampede-abiraterone-slowed-progression-advanced- 03.06.2017 Cancer Network prostate-cancer https://www.urotoday.com/conference-highlights/asco-2017/asco-2017-press-releases/96169-asco-abiraterone- 03.06.2017 UroToday slows-advanced-prostate-cancer-helps-patients-live-longer.html 03.06.2017 ASCO Post http://www.ascopost.com/News/55699 Institute of Cancer http://www.icr.ac.uk/news-archive/adding-abiraterone-to-standard-treatment-improves-prostate-cancer-survival- 07.06.2017 Research by-almost-40 03.06.2017 The Guardian https://www.theguardian.com/society/2017/jun/03/prostate-cancer-therapy-study-abiraterone http://www.independent.co.uk/news/health/hope-for-20000-prostate-cancer-patients-after-worlds-biggest- 03.06.2017 The Independent treatment-trial-a7770871.html http://ecancer.org/conference/940-2017-asco-annual-meeting/video/5973/asco-2017--following-the-practice- 04.06.2017 Ecancer changing-results-from-stampede.php 05.06.2017 Medical Xpress https://medicalxpress.com/news/2017-06-abiraterone-advanced-prostate-cancer-patients.html 03.06.17 Daily Mirror http://www.mirror.co.uk/news/uk-news/miracle-drug-combination-means-20000-10555490 http://www.express.co.uk/life-style/health/812697/Prostate-cancer-Drug-trial-breakthrough-DOUBLE-life- 04.06.17 Daily Express expectancy-treatment 03.06.17 BBC News http://www.bbc.co.uk/news/health-40131381 03.06.17 The Daily Telegraph http://www.telegraph.co.uk/news/2017/06/03/enormously-exciting-prostate-cancer-treatment-promises-hope/ 03.06.17 The Daily Mail http://www.dailymail.co.uk/health/article-4570406/Breakthrough-prostate-cancer-boosts-survival-rate.html https://www.thesun.co.uk/living/3718472/combination-of-drugs-could-cure-prostate-cancer-or-extend-the-life-of- 03.06.17 The Sun sufferers/ 03.06.2017 ICD Medicina http://www.institutodecancer.com.br/site/stampede-abiraterona-na-primeira-linha-cancer-de-prostata-avancado/ 36 Coverage summary DATE PUBLICATION LINK 03.06.17 MedScape http://www.medscape.com/viewarticle/881078 03.06.17 Prostate Cancer Foundation https://www.pcf.org/news/breaking-news-2017-asco-meeting-results-from-the-latitude-study/ http://www.targetedonc.com/conference/asco-2017/early-intervention-with-abiraterone-significantly- 03.06.17 Targeted Oncology reduces-risk-in-metastatic-prostate-cancer-results-of-2-studies-show http://www.cancerresearchuk.org/about-us/cancer-news/news-report/2017-06-03-giving-prostate- 03.06.17 CRUK cancer-drug-earlier-extends-lives-of-men-whose-disease-has-spread 03.06.17 EP Vantage http://epvantage.com/Universal/View.aspx?type=Story&id=711970&isEPVantage=yes&notSub=false 03.06.17 la1ere.francetvinfo.fr N/A 03.06.17 www.france24.com N/A 03.06.17 information.tv5monde.com N/A 03.06.17 www.nordnet.fr N/A AGENCE FRANCE PRESSE 03.06.17 N/A MONDIALES 03.06.17 www.paris-normandie.fr N/A 03.06.17 www.lepoint.fr N/A 03.06.17 www.ouest-france.fr N/A 03.06.17 www.leparisien.fr N/A 03.06.17 AFP N/A 37 Coverage summary DATE PUBLICATION LINK 03.06.2017 Dagens Medicin https://www.dagensmedicin.se/artiklar/2017/06/03/tidig-behandling-med-zytiga-gav-battre-overlevnad/ 03.06.2017 Dagens Medicin https://www.dagensmedisin.no/artikler/2017/06/03/-gjennombrudd-for-behandling-av-prostatakreft/ http://diariovision.com.ar/salud/medicamento-alarga-las-vidas-de-los-pacientes-con-cancer-de-prostata- 03.06.2017 Diario Vision avanzado/ 04.06.17 First Word Pharma https://www.firstwordpharma.com/node/1477011#axzz4j7KdNyln 04.06.17 Normangee Star http://normangeestar.net/2017/06/04/study-shows-early-zytiga-use-improves-prostate-cancer-survival/ Click Lancashire 04.06.17 http://clicklancashire.com/2017/06/04/j-js-zytiga-boosts-survival-in-new-severe-prostate-cancers.html Independent News http://am.asco.org/adt-plus-abiraterone-improves-survival-hormone-sensitive-advanced-prostate- 04.06.17 ASCO Daily News cancer?j=39315690&sfmc_sub=1808137054&l=18416124_HTML&u=670648835&mid=10831468&jb=53&et_ci d=39315690&et_rid=1808137054&linkid=ADT LE POPULAIRE DU 04.06.17 N/A CENTRE LE PETIT BLEU DE 04.06.17 N/A L'AGENAIS 04.06.17 portail.free.fr N/A 04.06.17 www.ladepeche.fr N/A 04.06.17 LA PROVENCE N/A 04.06.17 www.doctissimo.fr N/A 04.06.17 www.boursorama.com N/A 04.06.17 www.docteurjd.com N/A 38 Coverage summary DATE PUBLICATION LINK N/A 04.06.17 A DEPECHE DU MIDI 04.06.17 Quotidiano.it http://www.quotidiano.net/benessere/corpo%20e%20mente/prostata-abiraterone-1.3174256 http://www.philly.com/philly/health/topics/HealthDay723340_20170605_Drug_Extends_Lives_of_Patients_With 05.06.17 Philly.com _Advanced_Prostate_Cancer__Studies.html http://www.oncologynurseadvisor.com/asco-2017/abiraterone-addition-to-adt-improves-high-risk-prostate- 05.06.17 Oncology Nurse Adviser cancer-survival/article/666458/ http://www.pmlive.com/pharma_news/practice- 05.06.17 PM Live changing_data_for_j_and_js_zytiga_in_prostate_cancer_1194788# 05.06.17 The News Recorder http://www.thenewsrecorder.com/abiraterone-new-approach-for-treatment-of-prostate-cancer/36173 05.06.17 Pharmaphorum https://pharmaphorum.com/news/asco-data-points-zytiga/ 05.06.17 Newsweek http://www.newsweek.com/alectinib-alecensa-abiraterone-zytiga-survival-lung-cancer-prostate-cancer-620930 http://www.fiercepharma.com/pharma/pfizer-s-14b-medivation-deal-s-now-a-cautionary-m-a-tale-thanks-to- asco-data- analyst?utm_medium=nl&utm_source=internal&mrkid=22311031&mkt_tok=eyJpIjoiWkdZeU1UZGlaakJrWXpOa 05.06.17 Fierce Pharma iIsInQiOiJpUjVhb1NqbDNFRUF6b01BdStkZ2xLTkswWlRYaGpWVFRiazFLeThlMTYyOVFHTDZ6ckJaOURFVVNGazJV OHhJT3d3Y2NcL0ZjU3BhT2ZjanNTYnJDNVhuZDB0anJLRkh5N3NLR3ZYUkd0d01EdEU4UHQyZjFveVwvcDI0QlRBR